The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
318.90
-4.20 (-1.30%)
At close: Mar 5, 2026
The IBN SINA Pharmaceutical Industry Employees
The IBN SINA Pharmaceutical Industry had 5,200 employees as of June 30, 2025. The number of employees increased by 1,000 or 23.81% compared to the previous year.
Employees
5,200
Change (1Y)
1,000
Growth (1Y)
23.81%
Revenue / Employee
2.58M BDT
Profits / Employee
156.86K BDT
Market Cap
9.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5,200 | 1,000 | 23.81% |
| Jun 30, 2024 | 4,200 | 200 | 5.00% |
| Jun 30, 2023 | 4,000 | 0 | - |
| Jun 30, 2022 | 4,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Asiatic Laboratories | 737 |
| Orion Pharma | 2,954 |
| Navana Pharmaceuticals | 4,798 |
| The ACME Laboratories | 9,025 |
| Beacon Pharmaceuticals | 4,162 |
| Techno Drugs | 1,438 |
| Unilever Consumer Care | 61 |
| Renata | 8,366 |